<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Langley MR</submitter><funding>NCATS NIH HHS</funding><funding>National Multiple Sclerosis Society</funding><funding>NIDDK NIH HHS</funding><funding>Eugene and Marcia Applebaum Foundation</funding><funding>Mayo Clinic</funding><funding>NINDS NIH HHS</funding><funding>Minnesota State Spinal Cord Injury and Traumatic Brain Injury Research Program</funding><funding>Craig H. Neilsen Foundation</funding><pagination>165630</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7982965</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>1866(3)</volume><pubmed_abstract>Metabolic syndrome is a key risk factor and co-morbidity in multiple sclerosis (MS) and other neurological conditions, such that a better understanding of how a high fat diet contributes to oligodendrocyte loss and the capacity for myelin regeneration has the potential to highlight new treatment targets. Results demonstrate that modeling metabolic dysfunction in mice with chronic high fat diet (HFD) consumption promotes loss of oligodendrocyte progenitors across the brain and spinal cord. A number of transcriptomic and metabolomic changes in ER stress, mitochondrial dysfunction, and oxidative stress pathways in HFD-fed mouse spinal cords were also identified. Moreover, deficits in TCA cycle intermediates and mitochondrial respiration were observed in the chronic HFD spinal cord tissue. Oli</pubmed_abstract><journal>Biochimica et biophysica acta. Molecular basis of disease</journal><pubmed_title>High fat diet consumption results in mitochondrial dysfunction, oxidative stress, and oligodendrocyte loss in the central nervous system.</pubmed_title><pmcid>PMC7982965</pmcid><funding_grant_id>UL1TR000135</funding_grant_id><funding_grant_id>R01 NS120877</funding_grant_id><funding_grant_id>RG4958</funding_grant_id><funding_grant_id>R01NS052741</funding_grant_id><funding_grant_id>UL1 TR000135</funding_grant_id><funding_grant_id>R01 NS052741</funding_grant_id><funding_grant_id>U24 DK100469</funding_grant_id><funding_grant_id>U24DK100469</funding_grant_id><pubmed_authors>Scarisbrick IA</pubmed_authors><pubmed_authors>Yoon H</pubmed_authors><pubmed_authors>Kim HN</pubmed_authors><pubmed_authors>Choi CI</pubmed_authors><pubmed_authors>Langley MR</pubmed_authors><pubmed_authors>Matveyenko A</pubmed_authors><pubmed_authors>LeBrasseur NK</pubmed_authors><pubmed_authors>Lanza IR</pubmed_authors><pubmed_authors>Simon W</pubmed_authors><pubmed_authors>Kleppe L</pubmed_authors></additional><is_claimable>false</is_claimable><name>High fat diet consumption results in mitochondrial dysfunction, oxidative stress, and oligodendrocyte loss in the central nervous system.</name><description>Metabolic syndrome is a key risk factor and co-morbidity in multiple sclerosis (MS) and other neurological conditions, such that a better understanding of how a high fat diet contributes to oligodendrocyte loss and the capacity for myelin regeneration has the potential to highlight new treatment targets. Results demonstrate that modeling metabolic dysfunction in mice with chronic high fat diet (HFD) consumption promotes loss of oligodendrocyte progenitors across the brain and spinal cord. A number of transcriptomic and metabolomic changes in ER stress, mitochondrial dysfunction, and oxidative stress pathways in HFD-fed mouse spinal cords were also identified. Moreover, deficits in TCA cycle intermediates and mitochondrial respiration were observed in the chronic HFD spinal cord tissue. Oli</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Mar</publication><modification>2026-04-13T03:12:42.533Z</modification><creation>2025-02-19T02:12:58.342Z</creation></dates><accession>S-EPMC7982965</accession><cross_references><pubmed>31816440</pubmed><doi>10.1016/j.bbadis.2019.165630</doi></cross_references></HashMap>